Imperial College London


Faculty of MedicineNational Heart & Lung Institute

Professor of Respiratory Epidemiology



+44 (0)20 7594 8821j.quint




G48Emmanuel Kaye BuildingRoyal Brompton Campus





Jennifer Quint is a Professor of Respiratory Epidemiology at the National Heart and Lung Institute and Honorary Consultant Physician in Respiratory Medicine at the Royal Brompton and Imperial College London NHS Foundation Trusts.

Dr Quint’s research interests centre on the use of electronic health records to study chronic obstructive pulmonary disease (COPD) as well as other chronic respiratory diseases including asthma, ILD and bronchiectasis. She leads a clinical epidemiology research group whose work centres largely on understanding the relationship between cardiovascular and respiratory disease as well as maximising the quality, linkage and usage of routinely collected data for clinical and research purposes. The majority of her work has been on exacerbations of COPD, exploring both the effect of COPD exacerbations on vascular outcomes and the relationship between environmental factors and exacerbations of COPD. 



Quint J, O'Leary C, Venerus A, et al., 2021, Development and validation of a method to estimate COPD severity in multiple datasets: a retrospective study, Pulmonary Therapy, Vol:7, ISSN:2364-1746, Pages:119-132

Ngaosuwan K, Johnston DG, Godsland IF, et al., 2021, Full Mortality risk in patients with adrenal insufficiency using Prednisolone or Hydrocortisone: A Retrospective Cohort study., J Clin Endocrinol Metab

Alqahtani JS, Aquilina J, Bafadhel M, et al., 2021, Research priorities for exacerbations of COPD., Lancet Respir Med

Cook S, Eggen AE, Hopstock L, et al., 2021, Chronic Obstructive Pulmonary Disease (COPD) in population studies in Russia and Norway: comparison of prevalence, awareness and management, International Journal of Copd, Vol:16, ISSN:1176-9106, Pages:1353-1368

Gulea C, Quint JK, Zakeri R, 2021, Clinical and methodological considerations when interpreting meta-analyses of beta-blocker use in patients with chronic obstructive pulmonary disease., Eur Heart J

More Publications